GlycoMimetics and Crescent update merger investor presentation; no new deal terms disclosed

CRESCENT BIOPHARMA, INC.

GlycoMimetics furnished updated investor presentation (Exhibit 99.1) for proposed merger with Crescent Biopharma.
Presentation dated November 2024 contains no new financial terms, valuation, or timeline.
No changes to previously announced merger agreement structure or closing conditions were disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.